Group 1: Dividend Policy and Financial Performance - The company plans to maintain a dividend payout ratio of 43.3% for 2024, with a cash dividend of 1.30 CNY per 10 shares, distributing a total of 675,932,834.98 CNY, which accounts for 50.09% of the net profit attributable to shareholders for 2024 [2][3] - The company aims to distribute at least 50% of the annual distributable profit as cash dividends for the years 2024-2026 [3] - In Q1 2025, the net profit attributable to shareholders was 313 million CNY, representing a year-on-year increase of 21.63% [3] Group 2: Market Position and Competitive Strategy - The company is focusing on enhancing its core competitiveness by leveraging national strategies such as the "Belt and Road Initiative" and the Guangdong-Hong Kong-Macao Greater Bay Area [3][4] - The company has opened 17 inland ports and 32 sea-rail intermodal routes, enhancing its logistics network and regional competitiveness [4] - The company has added 6 new international routes in the first four months of 2025, expanding its service coverage to major trade regions [4] Group 3: Future Growth and Industry Outlook - The company plans to explore new business models and enhance operational efficiency to boost profitability, particularly in the Greater Bay Area and the Yangtze River Economic Belt [4][5] - The overall growth of China's coastal ports is expected to remain stable in 2025, although the growth rate may slow compared to 2024 [5][6] - The demand for coal is projected to increase slightly in 2025, while the throughput of metal ores is expected to remain stable due to ongoing trade tensions and a sluggish real estate market [6][7] Group 4: Operational Innovations - The Huangshi New Port is implementing an innovative "loading + mixing + trading" model for iron ore operations to enhance throughput and profitability [7] - The port has established modern storage facilities and a comprehensive transportation network to support its operations [7]

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

证券代码：000088 证券简称：盐田港 公告编号：2025-26 深圳市盐田港股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、股东大会审议通过的权益分派方案等情况 1.深圳市盐田港股份有限公司（以下简称"公司"或"本公司"） 于 2025 年 5 月 15 日召开公司 2024 年年度股东大会，审议通过了《公司 2024 年度利润分配预案》。公司股东大会同意 2024 年度利润分配方案 如下： 以公司现有总股本 5,199,483,346 股为基数，向全体股东每 10 股派 发现金红利 1.30 元（含税），本次分配 675,932,834.98 元。按 2024 年 度公司净利润的 10%提取法定盈余公积金 113,387,694.15 元，不提取任 意公积金。公司 2024 年度拟不送股，不进行资本公积金转增股本。 2.自 2024 年度利润分配方案披露至实施期间，公司股本总额未发生 变化。 3.本次实施的分配方案按照分配比例固定不变的原则，与股东大会 审议通过的分配方案及其调整原则一致。 4.本次实施分 ...

Group 1: Financial Performance - The company's Q1 2025 revenue was 171 million yuan, with a net profit attributable to shareholders of 313 million yuan, representing a year-on-year growth of 21.63% [2] - The net profit excluding non-recurring items was also 313 million yuan, showing a growth of 21.96% compared to the previous year [2] Group 2: Port Development and Operations - The company is leveraging national strategies such as the "Belt and Road Initiative" and the Guangdong-Hong Kong-Macao Greater Bay Area to enhance its port network and collaborative development [2] - In the first four months of 2025, the company added 6 new international shipping routes, expanding its service coverage to major trade areas in Europe, America, and Asia [3] - The port currently operates nearly 100 shipping routes, with an average of 6 daily flights to the United States and 4 to Europe, along with over 10 cross-border e-commerce shipping lines [3] Group 3: Dividend Policy - The company plans to significantly increase its cash dividend payout ratio in response to the new "National Nine Articles" policy, committing to distribute at least 50% of its distributable profits as cash dividends annually from 2024 to 2026 [3] - Since its listing, the company has distributed a total of 6.324 billion yuan in dividends and will continue to actively implement its cash dividend policy to reward shareholders [3] Group 4: Disclosure Compliance - The activity did not involve any undisclosed significant information [3]

Group 1 - The company will hold an online performance briefing for the year 2024 on May 28, 2025, from 15:00 to 16:00 [2][3] - Investors can submit questions before the meeting through a designated website [2][4] - The meeting aims to provide insights into the company's operational performance and development strategy [2][3] Group 2 - The company has approved the use of idle raised funds to purchase financial products, with a total limit of up to RMB 100 million [8][9] - The investment period for these financial products is valid for 12 months from the date of board approval [9] - The company has not used raised funds for financial products in the past twelve months, and the current investment will not affect the implementation of fundraising projects [13][14]

证券代码：000088 证券简称：盐田港 公告编号：2025-24 深圳市盐田港股份有限公司 关于使用闲置募集资金购买理财产品的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 不存在虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.投资种类：包括但不限于理财产品、结构性存款、可转 让大额存单等。 2.投资金额：在本次授权期限内任一时点使用闲置募集资 金购买理财产品总额度不超过人民币 1亿元（含 1亿元），在公 司董事会审议通过之日起 12 个月内有效，资金可以滚动使用。 3.特别风险提示：受政策风险、市场风险、流动性风险等 变化的影响，公司使用闲置募集资金购买安全性高、流动性好、 有保本约定的理财产品，其投资收益具有不确定性，敬请广大 投资者注意投资风险。 深圳市盐田港股份有限公司（以下简称"公司"或"盐田 港"）于 2025 年 3 月 21 日召开的第八届董事会临时会议和第八 届监事会临时会议，审议通过了《关于公司使用闲置募集资金 购买理财产品的议案》，同意公司在确保不影响募集资金投资 - 1 - 项目建设和公司正常经营的情况下，使用不超过人民币 1 亿元 的闲置募集资金购买理财 ...

会议问题征集：投资者可于 2025 年 5 月 28 日前访问网址 https://eseb.cn/1otN0wQxUTm 或扫描下方小程序码进行会前提问， 公司将通过本次业绩说明会上，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 证券代码：000088 证券简称：盐田港 公告编号：2025- 25 深圳市盐田港股份有限公司 关于举办 2024 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 不存在虚假记载、误导性陈述或重大遗漏。 重要内容提示： 深圳市盐田港股份有限公司（以下简称"公司"）已于 2025 年 4 月 24 日在巨潮资讯网上披露了《2024 年年度报告》及《2024 年年度 1 会议召开时间：2025 年 5 月 28 日（星期三）15:00-16:00 会议召开方式：网络互动方式 会议召开网址：价值在线（www.ir-online.cn） 报告摘要》。为便于广大投资者更加全面深入地了解公司经营业绩、 发展战略等情况，公司定于 2025 年 5 月 28 日（星期三）15:00-16:00 在"价值在线"（www.ir-online.cn）举办深 ...

国信证券股份有限公司 关于深圳市盐田港股份有限公司发行股份及支付现金购买资产 并募集配套资金暨关联交易之限售股份上市流通的核查意见 国信证券股份有限公司（以下简称"国信证券"或"独立财务顾问"）作为深圳 市盐田港股份有限公司（以下简称"上市公司"或"公司"）发行股份及支付现金购 买资产并募集配套资金暨关联交易之独立财务顾问，根据《上市公司重大资产重 组管理办法》《深圳证券交易所股票上市规则》等有关法律法规和规范性文件的 要求，对上市公司本次限售股份上市流通事项进行了核查，具体情况如下： 一、本次申请解除限售股份的基本情况 根据中国证券监督管理委员会《关于同意深圳市盐田港股份有限公司发行股 份购买资产并募集配套资金注册的批复》（证监许可〔2023〕2725 号），公司向特 定对象发行人民币普通股（A 股）913,758,995 股募集配套资金，本次发行的股票 已于 2024 年 11 月 18 日在深圳证券交易所上市，本次发行新增股份的性质为有 限售条件流通股，自上市之日起 6 个月内不得转让。 | 序号 | 发行对象名称 | 获配股数（股） | 获配金额（元） | 限售期 （月） | | --- | --- ...

登录新浪财经APP 搜索【信披】查看更多考评等级 1.本次解除限售股份数量为913,758,995股，占深圳市盐田港股份有限公司（以下简称"公司"）总股本的 17.57%，系公司发行股份及支付现金购买资产并募集配套资金项目中就募集配套资金向特定对象发行 的人民币普通股； 2.本次申请解除股份限售的发行对象共8名，发行时承诺的限售期为6个月； 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚 假记载、误导性陈述或重 大遗漏。 本次向特定对象发行股份募集配套资金之具体发行情况如下： 特别提示： ■ 二、本次限售股形成后至今公司股本数量变化情况 本次向特定对象发行股份募集配套资金完成后，公司的总股本为5,199,483,346股。本次限售股形成后至 今，公司未进行过送股、公积金转增股本等事项，股本数量未发生变化。 3.本次限售股份可上市流通日为2025年5月23日。 一、本次申请解除限售股份的基本情况 根据中国证券监督管理委员会《关于同意深圳市盐田港股份有限公司发行股份购买资产并募集配套资金 注册的批复》（证监许可〔2023〕2725号），公司向特定对象发行人民币普通股（A股）913,758,99 ...

特别提示： 限公司（以下简称"公司"）总股本的 17.57%，系公司发行股份及支付现 金购买资产并募集配套资金项目中就募集配套资金向特定对象发行的人 民币普通股； 一、本次申请解除限售股份的基本情况 伙） 根据中国证券监督管理委员会《关于同意深圳市盐田港股份有限公司 发行股份购买资产并募集配套资金注册的批复》（证监许可〔2023〕2725 号），公司向特定对象发行人民币普通股（A 股）913,758,995 股募集配套 资金，本次发行的股票已于 2024 年 11 月 18 日在深圳证券交易所上市， 本次发行新增股份的性质为有限售条件流通股，自上市之日起 6 个月内不 得转让。具体内容详见公司于 2024 年 11 月 15 日刊载在巨潮资讯网 （www.cninfo.com.cn）的相关公告。 本次向特定对象发行股份募集配套资金之具体发行情况如下： 获配股数 限售期 国新建源股权投资基金（成都）合伙企 业（有限合伙） 工银资本管理有限公司－北京诚通工 融股权投资基金（有限合伙） 赣州发展投资基金管理有限公司－赣 | 合计 | 913,758,995 | | 913,758,995 17.57% | | | ...